Defining the Endpoint: MRD-Guided BRAFI Withdrawal in Pediatric BRAF V600E-Positive LCH

Dmitrii Evseev; Daria Osipova; Irina Kalinina; Elena Raykina; Alexey Maschan; Michael Maschan

Defining the Endpoint: MRD-Guided BRAFI Withdrawal in Pediatric BRAF V600E-Positive LCH

Dmitrii Evseev^*
, Daria Osipova
, Irina Kalinina
, Elena Raykina
, Alexey Maschan
, Michael Maschan

^*Corresponding author for this work

Department of Pediatrics and Adolescent Medicine

Research output: Contribution to journal › Meeting Abstract › peer-review

Abstract

Abstracts From the 41st Annual Meeting of the Histiocyte Society Held Virtually and in Person in Seattle, Washington, USA From September 28–30, 2025

Original language	English
Journal	Pediatric Blood & Cancer
Volume	72
Issue number	55
Publication status	Published - Dec 2025

Fields of science

302035 Paediatrics and adolescent medicine

Cite this

@article{fab9652fdb2e43a3ad88fa430770c4dd,

title = "Defining the Endpoint: MRD-Guided BRAFI Withdrawal in Pediatric BRAF V600E-Positive LCH",

abstract = "Abstracts From the 41st Annual Meeting of the Histiocyte Society Held Virtually and in Person in Seattle, Washington, USA From September 28–30, 2025",

author = "Dmitrii Evseev and Daria Osipova and Irina Kalinina and Elena Raykina and Alexey Maschan and Michael Maschan",

year = "2025",

month = dec,

language = "English",

volume = "72",

journal = "Pediatric Blood \& Cancer",

issn = "1545-5009",

number = "55",

}

TY - JOUR

T1 - Defining the Endpoint: MRD-Guided BRAFI Withdrawal in Pediatric BRAF V600E-Positive LCH

AU - Evseev, Dmitrii

AU - Osipova, Daria

AU - Kalinina, Irina

AU - Raykina, Elena

AU - Maschan, Alexey

AU - Maschan, Michael

PY - 2025/12

Y1 - 2025/12

N2 - Abstracts From the 41st Annual Meeting of the Histiocyte Society Held Virtually and in Person in Seattle, Washington, USA From September 28–30, 2025

AB - Abstracts From the 41st Annual Meeting of the Histiocyte Society Held Virtually and in Person in Seattle, Washington, USA From September 28–30, 2025

UR - https://doi.org/10.1002/1545-5017.70014

M3 - Meeting Abstract

SN - 1545-5009

VL - 72

JO - Pediatric Blood & Cancer

JF - Pediatric Blood & Cancer

IS - 55

ER -

Defining the Endpoint: MRD-Guided BRAFI Withdrawal in Pediatric BRAF V600E-Positive LCH

Abstract

Fields of science

Other files and links

Cite this